Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance

BACKGROUND: Addition of chemotherapy to radiation has improved 5-year survival by 6%. However, the optimal dose and schedule of concurrent cisplatin is not well defined, though widely accepted practice is the weekly schedule of 40 mg/m(2) for 5 weeks. Repeated admissions for weekly cisplatin drain t...

Descripción completa

Detalles Bibliográficos
Autores principales: Katke, Aradhana, Nanda, R, Thejaswini, B, Pasha, Tanveer, Giri, GV, Babu, Govind, Pawar, Yashwant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726454/
https://www.ncbi.nlm.nih.gov/pubmed/34992867
http://dx.doi.org/10.5603/RPOR.a2021.0115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726454/
https://www.ncbi.nlm.nih.gov/pubmed/34992867
http://dx.doi.org/10.5603/RPOR.a2021.0115

Ejemplares similares